
CANSINO BIOLOGICS IN
6185
![]() |
|
234.2HKD | +1.83% |

Prev. | 230.0000 |
Open | 235.4000 |
High | 246.6000 |
Low | 231.0000 |
Volume | 1 950 178 |
Latest news
Chart CANSINO BIOLOGICS INC.
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Bullish | Neutral | Bullish |
Resistance | 249 | 271 | 271 |
Spread/Res. | -6,0% | -14% | -14% |
Spread/Supp. | 25% | 64% | 64% |
Support | 187 | 143 | 143 |
Financials
|
|
Company
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in...
>> Read more
>> Read more
Sector : |
Biopharmaceuticals
|
Calendar : |
2021-03-29 Earnings Release
|
Trading Rating : |
Investor Rating : | - |
Income Statement Evolution
Consensus
Mean consensus | BUY |
Number of Analysts | 6 |
Average target price | 171,22 CNY |
Last Close Price | 195,73 CNY |
Spread / Highest target | 11,1% |
Spread / Average Target | -12,5% |
Spread / Lowest Target | -76,4% |